X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (34) 34
humans (33) 33
male (28) 28
female (27) 27
middle aged (27) 27
aged (23) 23
diabetes mellitus, type 2 - drug therapy (22) 22
diabetes (19) 19
type 2 diabetes (19) 19
hypoglycemic agents - therapeutic use (17) 17
medicine, general & internal (17) 17
adult (16) 16
retrospective studies (15) 15
endocrinology & metabolism (14) 14
medicine, research & experimental (12) 12
hypoglycemia (11) 11
therapy (11) 11
mortality (10) 10
sulfonylurea compounds - therapeutic use (9) 9
united states (9) 9
medical research (8) 8
metformin (8) 8
young adult (8) 8
diabetes mellitus, type 2 - blood (7) 7
diabetes mellitus, type 2 - complications (7) 7
diabetes mellitus, type 2 - epidemiology (7) 7
disease (7) 7
glycemic control (7) 7
medicine, experimental (7) 7
mellitus (7) 7
risk (7) 7
type 2 diabetes mellitus (7) 7
aged, 80 and over (6) 6
care and treatment (6) 6
diabetes mellitus (6) 6
drug therapy (6) 6
hospitalization - economics (6) 6
hypoglycemia - chemically induced (6) 6
hypoglycemia - epidemiology (6) 6
hypoglycemic agents (6) 6
hypoglycemic agents - administration & dosage (6) 6
insulin (6) 6
logistic models (6) 6
original research (6) 6
patients (6) 6
sulfonylurea (6) 6
type-2 diabetes-mellitus (6) 6
adherence (5) 5
blood glucose - drug effects (5) 5
cohort studies (5) 5
drug therapy, combination (5) 5
efficacy (5) 5
epidemiology (5) 5
impact (5) 5
management (5) 5
medication adherence - statistics & numerical data (5) 5
monotherapy (5) 5
patient compliance (5) 5
prevalence (5) 5
risk factors (5) 5
sitagliptin (5) 5
treatment outcome (5) 5
adolescent (4) 4
algorithms (4) 4
analysis (4) 4
association (4) 4
blood glucose - metabolism (4) 4
cardiovascular disease (4) 4
compliance (4) 4
costs (4) 4
databases, factual (4) 4
diabetes mellitus, type 2 - economics (4) 4
diabetics (4) 4
endocrinology (4) 4
frequency (4) 4
glucose (4) 4
health aspects (4) 4
hyperglycemia (4) 4
hypoglycemic agents - adverse effects (4) 4
medical records (4) 4
medication (4) 4
population (4) 4
proportional hazards models (4) 4
pyrazines - therapeutic use (4) 4
research (4) 4
severity of illness index (4) 4
sitagliptin phosphate (4) 4
triazoles - therapeutic use (4) 4
united-states (4) 4
adults (3) 3
antihyperglycemic agents (3) 3
cardiovascular diseases (3) 3
cardiovascular risk (3) 3
care (3) 3
case-control studies (3) 3
clinical inertia (3) 3
combination (3) 3
comorbidity (3) 3
complications and side effects (3) 3
confidence intervals (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BMC Research Notes, ISSN 1756-0500, 2011, Volume 4, Issue 1, pp. 251 - 251
Some oral antihyperglycemic agents may increase risk of hypoglycemia and thereby reduce patient quality of life. Our objective was to assess the impact of the... 
Type 2 diabetes | Surveys | Care and treatment | Antihypertensive drugs | Hypoglycemia | Drug therapy | Health aspects
Journal Article
Journal of Diabetes and Its Complications, ISSN 1056-8727, 2017, Volume 31, Issue 7, pp. 1077 - 1078
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 10/2017, Volume 19, Issue 10, pp. 1425 - 1435
Aims: Certain treatments for type 2 diabetes mellitus cause hypoglycaemia and weight gain, and thus might counteract the benefits of intensive glucose control.... 
cardiovascular disease | body composition | sulphonylureas | hypoglycaemia | pharmaco‐epidemiology | observational study | pharmaco-epidemiology | TREATMENT MODALITIES | EVENTS | METAANALYSIS | SYMPTOMATIC HYPOGLYCEMIA | IMPACT | SATISFACTION | FREQUENCY | ENDOCRINOLOGY & METABOLISM | QUALITY-OF-LIFE | TYPE-2 DIABETES-MELLITUS | ASSOCIATION | Hypoglycemia - epidemiology | Prognosis | Humans | Middle Aged | Male | Weight Gain - physiology | Incidence | Young Adult | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Adult | Female | Weight Gain - drug effects | Retrospective Studies | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemia - diagnosis | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Cardiovascular Diseases - etiology | Sulfonylurea Compounds - therapeutic use | Biomarkers - analysis | Treatment Outcome | Diabetic Angiopathies - drug therapy | Diabetes Mellitus, Type 2 - diagnosis | Diabetic Angiopathies - epidemiology | Aged | Diabetes Mellitus, Type 2 - drug therapy | Cohort Studies | Type 2 diabetes | Medical research | Analysis | Electronic records | Medicine, Experimental | Medical records | Hypoglycemic agents | Cardiovascular diseases | Epidemiology | Heart attack | Myocardial infarction | Cerebral infarction | Stroke | Sulfonylurea | Diabetes mellitus | Cardiovascular disease | Diabetes | Congestive heart failure | Hypoglycemia | Health risk assessment | Electronic medical records | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 01/2018, Volume 20, Issue 1, pp. 50 - 59
AimsTo analyse the prevalence of severe hypoglycaemia in patients with type 2 diabetes (T2DM) treated with antihyperglycaemic agents (AHA) and requiring... 
emergency department | hypoglycaemia | type 2 diabetes | MANAGEMENT | RISK | MELLITUS | DEPARTMENT VISITS | COST | HYPERGLYCEMIA | GLUCOSE | ENDOCRINOLOGY & METABOLISM | PEOPLE | ASSOCIATION | Hypoglycemia - epidemiology | Hypoglycemia - therapy | Prevalence | Humans | Middle Aged | Diabetes Mellitus, Type 2 - diet therapy | Male | Risk | Drug Therapy, Combination - adverse effects | Hypoglycemia - physiopathology | Portugal - epidemiology | Female | Hypoglycemia - chemically induced | Insulin Secretion | Hypoglycemic Agents - therapeutic use | Length of Stay | Severity of Illness Index | Emergency Service, Hospital | Cross-Sectional Studies | Combined Modality Therapy - adverse effects | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - mortality | Incretins - adverse effects | Syncope - etiology | Aged | Diet, Diabetic - adverse effects | Incretins - therapeutic use | Patient Compliance | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Insulin - therapeutic use | Elder Nutritional Physiological Phenomena - drug effects | Type 2 diabetes | Medicine, Experimental | Medical research | Emergency service | Hospitals | Admission and discharge | Syncope | Diabetes mellitus | Emergency medical care | Diabetes | Hypoglycemia | Primary care | Insulin | Index Medicus
Journal Article
Diabetes, Obesity and Metabolism, ISSN 1462-8902, 07/2018, Volume 20, Issue 7, pp. 1732 - 1739
Aims: TECOS, a cardiovascular safety trial (identifier: NCT00790205) involving 14 671 patients with type 2 diabetes and cardiovascular disease, demonstrated... 
costs | sitagliptin | dipeptidyl peptidase‐4 inhibitor | cost analysis | diabetes | dipeptidyl peptidase-4 inhibitor | MORTALITY | GLUCOSE | DISEASE | ENDOCRINOLOGY & METABOLISM | RISK | DEATH | MELLITUS | Hypoglycemic Agents - economics | Length of Stay - economics | United States | Humans | Middle Aged | Hospitalization - statistics & numerical data | Diabetes Mellitus, Type 2 - economics | Male | Health Resources - statistics & numerical data | Drug Costs - statistics & numerical data | Female | Equivalence Trials as Topic | Length of Stay - statistics & numerical data | Hypoglycemic Agents - therapeutic use | Proportional Hazards Models | Health Resources - economics | Linear Models | Sitagliptin Phosphate - economics | Randomized Controlled Trials as Topic | Cost-Benefit Analysis | Health Care Costs - statistics & numerical data | Sitagliptin Phosphate - therapeutic use | Aged | Ambulatory Care - economics | Ambulatory Care - statistics & numerical data | Diabetes Mellitus, Type 2 - drug therapy | Longitudinal Studies | Hospitalization - economics | Type 2 diabetes | Hypoglycemic agents | Valuation | Medical economics | Analysis | Patient outcomes | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent) | Patients | Diabetes mellitus | Generalized linear models | Index Medicus | Clinical Medicine | costs; cost analysis; diabetes; dipeptidyl peptidase-4 inhibitor; sitagliptin | Medical and Health Sciences | Endokrinologi och diabetes | Medicin och hälsovetenskap | Klinisk medicin | Endocrinology and Diabetes
Journal Article
Journal Article
International Journal of Clinical Practice, ISSN 1368-5031, 06/2017, Volume 71, Issue 6, pp. e12958 - n/a
Journal Article
Current medical research and opinion, ISSN 0300-7995, 07/2019, pp. 1 - 1
To assess demographic and clinical characteristics associated with clinical inertia in a real-world cohort of type 2 diabetes mellitus patients not at... 
Index Medicus
Journal Article
Journal Article
Urology, ISSN 0090-4295, 2009, Volume 74, Issue 1, pp. 34 - 38
Journal Article